Pharmafile Logo
Pharmafocus logo
Advanced Search

Pharma manufacturing news in brief

August 14, 2012
Manufacturing and Production Advanced Bioscience, Almac, Amneal, Cipla, Isis, Sanofi Pasteur

Cipla opening three new API plants as Indian trade delegations forges closer ties with Sri Lanka; plus facility updates from …

News
Amgen image

Amgen unveils plan to close Epogen plant

August 14, 2012
Manufacturing and Production Amgen, Epogen, cuts, omontys

Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …

News

De Facto in management buy out

August 14, 2012
Medical Communications Chime Communications, De Facto Communications

Healthcare and life sciences communications specialist De Facto Communications has completed a management buyout of the business from Chime Communications.The …

News

WuXi continues strong growth

August 14, 2012
Manufacturing and Production China, WuXi

Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …

News
Avastin image

Avastin sees success in brain cancer trial

August 13, 2012
Research and Development, Sales and Marketing R&D, avastin, brain cancer

A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …

News
Pfizer image

Torisel-Avastin combo fails in kidney cancer

August 13, 2012
Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …

News
Lucentis image

Lucentis gains new licence in the US

August 13, 2012
Sales and Marketing Eylea, FDA, Lucentis, approval, avastin, wet AMD

Roche’s eye drug Lucentis has gained a new licence in the US to treat diabetic macular oedema. The FDA has …

News

Contract research news in brief

August 10, 2012
Research and Development Accenture, Charles River Labs, ICON, Octagon Research Solutions, Phlexglobal, Quanticate, Verum

ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.

News
merck serono image

Merck Serono says dispute over Geneva closure is resolved

August 10, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts

Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …

News
FDA image

FDA approves leukaemia drug Marqibo

August 10, 2012
Sales and Marketing FDA, Marqibo, Talon Therapeutics, lilly

The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of …

News

Pfizer signs drug profiling deal with Nodality

August 10, 2012
Research and Development, Sales and Marketing Lupus, Nodality, Pfizer, SCNP

Pfizer has signed a multi-year drug profiling deal with Nodality to help get the best from its autoimmune disease compounds. …

News
screen_shot_2012-08-10_at_10

Former Pfizer head Kindler joins Lux Capital

August 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kindler, Pfizer

Venture capital firm Lux Capital has appointed former Pfizer chairman and chief executive Jeff Kindler as a partner. Kindler will …

Appointment

Fuji buys Thai manufacturing facility from DKSH

August 9, 2012
Manufacturing and Production DKSH, Fuji, OLIC, Thai

Japan’s Fuji Pharma has bought Thailand’s largest pharmaceutical contract manufacturing organisation OLIC from current owner DKSH. In a deal that …

News
Amanda Paxon image

Working Life: Amanda Paxon

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amanda Paxon, Boehringer Ingelheim, Working Life

 How did you find your way into your current role? Through a combination of good luck and hard work! I …

Feature
Zelboraf image

NICE still minded not to recommend Zelboraf

August 9, 2012
Sales and Marketing BMS, NICE, QALY, Yervoy, Zelboraf

NICE is asking Roche for more information about its melanoma pill Zelboraf, saying it is still too expensive and its …

News

Amgen scraps pancreatic cancer drug

August 9, 2012
Research and Development, Sales and Marketing Amgen, GAMMA, Ganitumab, pancreatic

Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …

News
Nicholson image

Nicholson to end NHS black listing of drugs

August 9, 2012
Sales and Marketing IHW, NHS, NICE, Sir David Nicholson, formulary

The chief executive of the NHS is looking to stamp out black listing of NICE-approved medicines. In a letter to …

News

Cambridge University gains stem cell centre funding

August 9, 2012
Research and Development, Sales and Marketing Cambridge, MRC, Wellcome Trust, stem cell

The Wellcome Trust and the Medical Research Council are investing £8 million into a new stem cell research centre. The …

News
David Willetts image

UK government to create four new ‘eHealth’ centres

August 9, 2012
Sales and Marketing MRC, NHS, data, eHealth, investment, patient records

A consortium of ten UK government and charity groups has invested £19 million to create a series of eHealth research …

News
screen_shot_2012-08-09_at_11

NHS Board appointments

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS, government

Further Commissioning Support Unit (CSU) managing directors have been announced by the NHS Board Authority.

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026